Lv1
18 积分 2024-02-05 加入
Body Mass Index Thresholds for Asians: A Race Correction in Need of Correction?
9天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
10天前
已完结
17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease
15天前
已完结
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
16天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
21天前
已完结
Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study
1个月前
已完结
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
1个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
1个月前
已完结
The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality
1个月前
已完结
Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults
1个月前
已完结
皖公网安备34019202002308
